---
document_datetime: 2023-10-31 11:06:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/pandemic-influenza-vaccine-h5n1-baxter-epar-all-authorised-presentations_en.pdf
document_name: pandemic-influenza-vaccine-h5n1-baxter-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.771621
conversion_datetime: 2025-12-28 11:19:26.251852
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name                          | Strength               | Pharmaceutical Form      | Route of Administration   | Packaging                                                       | Content (concentration)   | Package size   |
|-----------------|----------------------------------------|------------------------|--------------------------|---------------------------|-----------------------------------------------------------------|---------------------------|----------------|
| EU/1/09/571/001 | PANDEMIC INFLUENZA VACCINE H5N1 BAXTER | 7.5 micrograms/ 0.5 ml | Suspension for injection | Intramuscular use         | Multi-dose vial (glass)                                         | 0.5 ml                    | 20 vials       |
| EU/1/09/571/002 | PANDEMIC INFLUENZA VACCINE H5N1 BAXTER | 7.5 micrograms/ 0.5 ml | Suspension for injection | Intramuscular use         | Single-dose prefilled syringe (glass) without needle authorised | 0.5 ml                    | 1 syringe      |

<!-- image -->